Metabolomic Characterization of Neonates Born to Hyperthyroid Mothers

Area of Science:

• Endocrinology
• Metabolomics
• Neonatal Health

Background:

• Hyperthyroidism in pregnancy requires treatment, often with propylthiouracil (PTU).
• Maternal PTU treatment aims to normalize thyroid hormone levels but may affect fetal development.
• Understanding the metabolic impact of prenatal PTU exposure on neonates is crucial.

Purpose of the Study:

• To compare blood metabolic profiles of neonates exposed to maternal PTU treatment versus healthy controls.
• To identify specific metabolic alterations and affected pathways in PTU-exposed neonates.
• To evaluate potential impacts on fetal health despite maternal PTU therapy.

Main Methods:

• Blood samples were collected from 31 PTU-exposed neonates and 36 healthy controls.
• Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used for metabolite analysis.
• Differential metabolite analysis and pathway enrichment analysis were performed.

Main Results:

• Neonates exposed to PTU showed distinct blood metabolic profiles compared to controls.
• Significantly reduced levels of histidine and aspartic acid were observed in PTU-exposed neonates.
• Affected pathways included ammonia recycling and glycine/serine metabolism, crucial for biosynthesis.

Conclusions:

• Prenatal exposure to PTU during maternal hyperthyroidism causes characteristic neonatal metabolic profile alterations.
• These metabolic changes suggest potential impacts on protein and nucleotide biosynthesis.
• Close monitoring of growth and developmental outcomes is recommended for PTU-exposed neonates.